CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 116 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,129,241 | +21.0% | 2,896,074 | -26.7% | 1.83% | +41.9% |
| Q2 2023 | $71,193,344 | +12.2% | 3,950,796 | 0.0% | 1.29% | +3.5% |
| Q1 2023 | $63,449,784 | +8.5% | 3,950,796 | +23.6% | 1.25% | +11.3% |
| Q4 2022 | $58,502,831 | -6.8% | 3,196,876 | 0.0% | 1.12% | -4.0% |
| Q3 2022 | $62,787,000 | +5.3% | 3,196,876 | 0.0% | 1.17% | +8.0% |
| Q2 2022 | $59,622,000 | -15.0% | 3,196,876 | 0.0% | 1.08% | -5.1% |
| Q1 2022 | $70,171,000 | -22.7% | 3,196,876 | 0.0% | 1.14% | -2.6% |
| Q4 2021 | $90,823,000 | +44.0% | 3,196,876 | +6.7% | 1.17% | +68.5% |
| Q3 2021 | $63,084,000 | +11.7% | 2,996,876 | 0.0% | 0.69% | +21.4% |
| Q2 2021 | $56,491,000 | +34.3% | 2,996,876 | +8.8% | 0.57% | +45.3% |
| Q1 2021 | $42,075,000 | +8.3% | 2,753,567 | 0.0% | 0.39% | +15.6% |
| Q4 2020 | $38,853,000 | -10.0% | 2,753,567 | 0.0% | 0.34% | -37.3% |
| Q3 2020 | $43,148,000 | -10.6% | 2,753,567 | 0.0% | 0.54% | -20.2% |
| Q2 2020 | $48,242,000 | +60.9% | 2,753,567 | +35.0% | 0.68% | +34.7% |
| Q1 2020 | $29,977,000 | -41.4% | 2,039,282 | 0.0% | 0.50% | -31.0% |
| Q4 2019 | $51,166,000 | +66.8% | 2,039,282 | 0.0% | 0.73% | +25.4% |
| Q3 2019 | $30,671,000 | -39.8% | 2,039,282 | 0.0% | 0.58% | -26.3% |
| Q2 2019 | $50,982,000 | +17.0% | 2,039,282 | +6.5% | 0.79% | +17.2% |
| Q1 2019 | $43,569,000 | -24.1% | 1,914,282 | 0.0% | 0.67% | -36.5% |
| Q4 2018 | $57,409,000 | +4.7% | 1,914,282 | 0.0% | 1.06% | +60.7% |
| Q3 2018 | $54,844,000 | – | 1,914,282 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,030,616 | $31,028,000 | 6.04% |
| 5AM Venture Management, LLC | 1,362,286 | $20,816,000 | 3.75% |
| Burrage Capital Management LLC | 272,393 | $4,162,000 | 3.37% |
| Altium Capital Management LP | 361,930 | $5,530,000 | 1.54% |
| Vivo Capital, LLC | 2,214,138 | $33,832,000 | 1.19% |
| Bain Capital Life Sciences Investors, LLC | 1,071,428 | $16,371,000 | 0.93% |
| Perceptive Advisors | 3,659,381 | $51,606,000 | 0.65% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,154,000 | 0.50% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,003,688 | $30,616,000 | 0.45% |
| Opaleye Management Inc. | 188,000 | $2,873,000 | 0.42% |